RT Journal Article
T1 Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14).
A1 Cobo-Cuenca, Ana I
A1 Rodriguez-Borrego, Maria-Aurora
A1 Hidalgo-Lopezosa, Pedro
A1 Rodriguez-Muñoz, Pedro M
A1 Martins, Manuela
A1 Carmona-Torres, Juan M
K1 cervical cancer
K1 cancercytology
K1 Spain
K1 screening
K1 cervical cancer screening
AB Cervical cancer has decreased in developed countries thanks to cytology screening programmes. The aims of this study were To analyse the frequency and evolution of performing cytology tests and to determine the variables that influence their use. Cross-sectional study of non-institutionalized women who participated in the national health survey (2006, 2011/12) and the European Health Survey in Spain (2009, 2014). Study variables: cytology-testing, time since last cytology-test, reason for performing the test, age, nationality, marital status, social status, education level and place of residence. The study evaluated 53 628 women in Spain over 15 years old, with a mean age of 52.68 (SD ± 19.12). About 94.1% were Spanish, 49.2% were married and 77.2% lived with a partner. In 2014, 72% had a cytology test, a number that increased significantly. Women aged 25-65 were 5.13 times more likely to undergo a cytology test than those aged 15-24 years old (odds ratio (OR): 5.13; P  0.001); those of social classes I and II (high) were 1.2 more likely to undergo a cytology test than those of low social class (P = 0.026); and Spanish women were 1.74 times more likely to undergo a cytology test than foreigners living in Spain (P  Frequency of cytology testing has increased in the last few years. Screening for cervical cancer is associated with higher social status, education level, age, and not being foreign.
PB Oxford University Press
YR 2018
FD 2018-02-12
LK http://hdl.handle.net/10668/12138
UL http://hdl.handle.net/10668/12138
LA en
NO Cobo-Cuenca AI, Rodríguez-Borrego MA, Hidalgo-Lópezosa P, Rodríguez-Muñoz PM, Martins M, Carmona-Torres JM. Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14). Eur J Public Health. 2018 Jun 1;28(3):410-415.
DS RISalud
RD Apr 5, 2025